Related Experiment Video
Updated: May 19, 2026
11:06
Comparison of Tobacco Host Cell Protein Removal Methods by Blanching Intact Plants or by Heat Treatment of Extracts
Published on: August 8, 2016
Locust bean gum: Exploring its potential for biopharmaceutical applications.
1CBME - Centre for Molecular and Structural Biomedicine/IBB - Institute for Biotechnology and Bioengineering, Faculty of Sciences and Technology, University of Algarve, Campus de Gambelas, Faro, Portugal.
Journal of Pharmacy & Bioallied Sciences
|August 28, 2012
Summary
Locust bean gum, a galactomannan polysaccharide, offers significant potential in biopharmaceutical applications due to its gelling capacity and biodegradability. This review highlights its properties and synergistic interactions for advanced drug delivery systems.
Area of Science:
- Biomaterials Science
- Polymer Chemistry
- Pharmacology
Background:
- Polysaccharides are increasingly utilized in biomedical and biopharmaceutical fields.
- Locust bean gum (LBG) is a galactomannan extracted from Ceratonia siliqua seeds.
- LBG possesses notable characteristics, including high gelling capacity, making it suitable for biopharmaceutical uses.
Purpose of the Study:
- To review critical aspects of locust bean gum for biopharmaceutical applications.
- To explore its physicochemical properties and synergistic interactions with other biomaterials.
- To discuss its potential for in vivo biodegradation and specific applications.
Main Methods:
- Literature review of locust bean gum properties and applications.
- Analysis of physicochemical characteristics relevant to biopharmaceutical formulations.
- Exploration of biodegradation potential and synergistic effects.
Main Results:
- Locust bean gum exhibits excellent gelling properties.
- It demonstrates strong synergistic interactions with various biomaterials.
- In vivo biodegradation potential is a key feature for its application.
Conclusions:
- Locust bean gum is a promising polysaccharide for biopharmaceutical applications.
- Its properties support its use in drug delivery and other biomedical fields.
- Further research into its biodegradation and applications is warranted.
Related Concept Videos
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
01:27Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
01:27Bioplastics
Bioplastics derived from microbial processes present a sustainable alternative to conventional petroleum-based plastics. Among these, polyhydroxyalkanoates (PHAs), particularly polyhydroxybutyrates (PHBs), have emerged as prominent candidates due to their biodegradability and biocompatibility. These polymers are synthesized by a variety of bacteria, such as Cupriavidus necator and Pseudomonas putida, which naturally accumulate PHAs as intracellular carbon and energy reserves, especially under...
01:18Production of Biopesticides
Biopesticides offer a sustainable alternative to chemical pesticides, utilizing microbial agents to control agricultural pests. Bacillus thuringiensis (Bt) is a widely employed bacterium known for its potent insecticidal activity. Bt biopesticides are favored for their specificity to insect pests, minimal environmental impact, and natural degradability.Mechanism of Bt Toxin Action Bt produces insecticidal crystal (Cry) proteins during its sporulation phase. These proteins form parasporal...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...